165 related articles for article (PubMed ID: 22104541)
21. Improvement in lung cancer outcomes with targeted therapies: an update for family physicians.
Rolfo C; Passiglia F; Ostrowski M; Farracho L; Ondøichová T; Dolcan A; Castiglia M; Remmen R; Papadimitriou K; Pauwels P
J Am Board Fam Med; 2015; 28(1):124-33. PubMed ID: 25567833
[TBL] [Abstract][Full Text] [Related]
22. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
[TBL] [Abstract][Full Text] [Related]
23. Targeting receptor tyrosine kinases in solid tumors.
Zhang J; Hochwald SN
Surg Oncol Clin N Am; 2013 Oct; 22(4):685-703. PubMed ID: 24012395
[TBL] [Abstract][Full Text] [Related]
24. Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer.
Halliday PR; Blakely CM; Bivona TG
Curr Oncol Rep; 2019 Feb; 21(3):21. PubMed ID: 30806814
[TBL] [Abstract][Full Text] [Related]
25. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
Zarogoulidis P; Yarmus L; Zarogoulidis K
Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
[No Abstract] [Full Text] [Related]
26. Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer.
Riess JW; Neal JW
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S385-6. PubMed ID: 23160327
[No Abstract] [Full Text] [Related]
27. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
McIntire M; Redston M
Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
[TBL] [Abstract][Full Text] [Related]
28. [Is chemotherapy still a valid option for oncogene-addicted lung cancer? Yes].
Besse B
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S93-5. PubMed ID: 26118884
[TBL] [Abstract][Full Text] [Related]
29. The molecular basis of targeting protein kinases in cancer therapeutics.
Tsai CJ; Nussinov R
Semin Cancer Biol; 2013 Aug; 23(4):235-42. PubMed ID: 23651790
[TBL] [Abstract][Full Text] [Related]
30. Functional drug-gene interactions in lung cancer.
Smida M; Nijman SM
Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819
[TBL] [Abstract][Full Text] [Related]
31. Lung cancer genotype-based therapy and predictive biomarkers: present and future.
Cagle PT; Allen TC
Arch Pathol Lab Med; 2012 Dec; 136(12):1482-91. PubMed ID: 23194040
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase Cs in lung cancer: a promising target for therapies.
Fan C; Li Y; Jia J
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S74-9. PubMed ID: 24135246
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.
Savonarola A; Palmirotta R; Guadagni F; Silvestris F
Pharmacogenomics J; 2012 Aug; 12(4):277-86. PubMed ID: 22760589
[TBL] [Abstract][Full Text] [Related]
34. New targeted therapies for gastric cancer.
Asaoka Y; Ikenoue T; Koike K
Expert Opin Investig Drugs; 2011 May; 20(5):595-604. PubMed ID: 21406037
[TBL] [Abstract][Full Text] [Related]
35. Advances in treatment of lung cancer with targeted therapy.
Cagle PT; Chirieac LR
Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancer.
Reinmuth N; Meister M; Muley T; Steins M; Kreuter M; Herth FJ; Hoffmann H; Dienemann H; Thomas M
Int J Cancer; 2006 Aug; 119(4):727-34. PubMed ID: 16557579
[TBL] [Abstract][Full Text] [Related]
37. Receptor Tyrosine Kinase-Targeted Cancer Therapy.
Yamaoka T; Kusumoto S; Ando K; Ohba M; Ohmori T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404198
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy in nonsmall cell lung cancer.
Puri T
Indian J Cancer; 2017; 54(1):83-88. PubMed ID: 29199670
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of acquired resistance to targeted cancer therapies.
Lackner MR; Wilson TR; Settleman J
Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
[TBL] [Abstract][Full Text] [Related]
40. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
Merlio JP
Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
